Ann Birner

508 total citations
14 papers, 304 citations indexed

About

Ann Birner is a scholar working on Genetics, Dermatology and Oncology. According to data from OpenAlex, Ann Birner has authored 14 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Dermatology and 5 papers in Oncology. Recurrent topics in Ann Birner's work include Chronic Lymphocytic Leukemia Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Chemotherapy-related skin toxicity (5 papers). Ann Birner is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Chemotherapy-related skin toxicity (5 papers). Ann Birner collaborates with scholars based in United States. Ann Birner's co-authors include Steven P. Treon, Irene M. Ghobrial, Marybeth Nelson, Dixie Esseltine, Thomas J. Myers, Patricia Sheehy, Christopher J. Patterson, Andy Boral, Jacob D. Soumerai and George P. Keogh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Ann Birner

14 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Birner United States	6	191	157	93	63	57	14	304
Santiago Osorio Spain	9	137 0.7×	16 0.1×	188 2.0×	53 0.8×	23 0.4×	28	247
Kian Meng Chang Malaysia	8	71 0.4×	15 0.1×	100 1.1×	28 0.4×	17 0.3×	29	198
Stéphane Darre France	6	65 0.3×	37 0.2×	146 1.6×	35 0.6×	26 0.5×	8	246
Ulf Christian Frølund Denmark	10	75 0.4×	19 0.1×	247 2.7×	156 2.5×	16 0.3×	27	318
Birgitta Lauri Sweden	7	219 1.1×	90 0.6×	201 2.2×	35 0.6×	39 0.7×	15	324
Jeff Schriber United States	4	30 0.2×	39 0.2×	228 2.5×	76 1.2×	54 0.9×	5	321
Hussein Awada United States	9	39 0.2×	19 0.1×	99 1.1×	64 1.0×	16 0.3×	41	223
Kerry Taylor Australia	11	260 1.4×	21 0.1×	328 3.5×	14 0.2×	15 0.3×	23	373
Andrea Heider Germany	10	106 0.6×	141 0.9×	29 0.3×	179 2.8×	11 0.2×	16	294
Maher Aassi Switzerland	8	72 0.4×	38 0.2×	106 1.1×	12 0.2×	105 1.8×	13	309

Countries citing papers authored by Ann Birner

Since Specialization

Citations

This map shows the geographic impact of Ann Birner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Birner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Birner more than expected).

Fields of papers citing papers by Ann Birner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Birner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Birner. The network helps show where Ann Birner may publish in the future.

Co-authorship network of co-authors of Ann Birner

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Birner. A scholar is included among the top collaborators of Ann Birner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Birner. Ann Birner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

McMillin, Douglas W., Zachary R. Hunter, Jake Delmore, et al.. (2010). Activity of the NEDD8-specific inhibitor MLN 4924 in multiple myeloma and Waldenström's macroglobulinemia, and effect on miRNA expression.. Journal of Clinical Oncology. 28(15_suppl). 8110–8110. 1 indexed citations

McMillin, Douglas W., Zachary R. Hunter, Jake Delmore, et al.. (2010). MLN4924, a Novel Investigational NEDD8 Activating Enzyme Inhibitor, Exhibits Preclinical Activity In Multiple Myeloma and Waldenstrom's Macroglobulinemia through Mechanism Distinct From Existing Proteasome Inhibitors. Blood. 116(21). 2988–2988. 4 indexed citations

Leduc, Renee, Marybeth Nelson, Amy Sam, et al.. (2009). A573 Phase I Trial of CCI-779 and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma. Clinical Lymphoma & Myeloma. 9. S86–S86. 1 indexed citations

Schlossman, R, Stacey Chuma, Renee Leduc, et al.. (2009). A535 Phase II Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenström Macroglobulinemia. Clinical Lymphoma & Myeloma. 9. S83–S84. 1 indexed citations

Treon, Steven P., Leukothea Ioakimidis, Jacob D. Soumerai, et al.. (2009). Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180. Journal of Clinical Oncology. 27(23). 3830–3835. 187 indexed citations

Ghobrial, Irene M., Jeffrey Matous, Swaminathan P. Iyer, et al.. (2008). Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia. Blood. 112(11). 832–832. 4 indexed citations

Ghobrial, Irene M., Nikhil C. Munshi, Robert Schlossman, et al.. (2008). Phase I Trial of CCI-779 (Temsirolimus) and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma. Blood. 112(11). 3696–3696. 11 indexed citations

Ghobrial, Irene M., Swaminathan P. Iyer, Ashraf Badros, et al.. (2007). Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.. Blood. 110(11). 4494–4494. 5 indexed citations

Birner, Ann, et al.. (2006). Program to Support Safe Administration of Oral Chemotherapy. Journal of Oncology Practice. 2(1). 5–6. 9 indexed citations

10.

Birner, Ann, et al.. (2006). Program to Support Safe Administration of Oral Chemotherapy. Journal of Oncology Practice. 2(1). 5–6. 15 indexed citations

11.

Birner, Ann, et al.. (2005). Oral Chemotherapy. Clinical journal of oncology nursing. 9(1). 107–109. 1 indexed citations

12.

Birner, Ann. (2003). Pharmacology of Oral Chemotherapy Agents. Clinical journal of oncology nursing. 7(0). 11–19. 24 indexed citations

13.

Birner, Ann. (2003). Safe Administration of Oral Chemotherapy. Clinical journal of oncology nursing. 7(2). 158–162. 37 indexed citations

14.

Birner, Ann & Louise P. Meyer. (2001). Photosensitivity Associated with Fluorouracil, Prochlorperazine, and Topical Tretinoin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(2). 258–260. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact